Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Depreciation and Depletion: 2023-2025

Historic Depreciation and Depletion for Zenas BioPharma (ZBIO) over the last 2 years, with Sep 2025 value amounting to $11,000.

  • Zenas BioPharma's Depreciation and Depletion fell 69.44% to $11,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $79,000, marking a year-over-year decrease of 41.04%. This contributed to the annual value of $137,000 for FY2024, which is 21.24% up from last year.
  • Zenas BioPharma's Depreciation and Depletion amounted to $11,000 in Q3 2025, which was down 8.33% from $12,000 recorded in Q2 2025.
  • Zenas BioPharma's 5-year Depreciation and Depletion high stood at $36,000 for Q3 2024, and its period low was $11,000 during Q3 2025.
  • For the 3-year period, Zenas BioPharma's Depreciation and Depletion averaged around $26,625, with its median value being $31,500 (2023).
  • In the last 5 years, Zenas BioPharma's Depreciation and Depletion rose by 10.00% in 2024 and then slumped by 69.44% in 2025.
  • Zenas BioPharma's Depreciation and Depletion (Quarterly) stood at $30,000 in 2023, then rose by 10.00% to $33,000 in 2024, then tumbled by 69.44% to $11,000 in 2025.
  • Its Depreciation and Depletion stands at $11,000 for Q3 2025, versus $12,000 for Q2 2025 and $23,000 for Q1 2025.